Literature DB >> 7757994

Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.

G A Mayr1, M Reed, P Wang, Y Wang, J F Schweds, P Tegtmeyer.   

Abstract

Murine tumor suppressor p53 is phosphorylated in the NH2-terminal transactivating domain at serines 9, 18, and 37. Change of any one of these serines to either alanine or aspartic acid did not alter p53 suppression of transformation of rat embryo fibroblasts by activated ras and E1A. Change of any two of these serines to alanines, however, led to a significant decrease in suppressor function. Substitution of alanines for all three serines caused the most severe loss of suppression and also reduced transactivation functions. The triple substitution had no apparent effects on intracellular accumulation or localization of p53, oligomerization, DNA binding, or interaction with the TFIID TATA-binding protein. In contrast, triple substitution of aspartic acid for serines 9, 18, and 37 had minimal effects on suppression and transactivation by p53. These results argue strongly that phosphorylation of serines 9, 18, and 37 facilitates the suppression and transactivation functions of p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757994

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Stabilization and activation of p53 are regulated independently by different phosphorylation events.

Authors:  M V Chernov; C V Ramana; V V Adler; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.

Authors:  B F Müller-Tiemann; T D Halazonetis; J J Elting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

4.  p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.

Authors:  L J Ko; S Y Shieh; X Chen; L Jayaraman; K Tamai; Y Taya; C Prives; Z Q Pan
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Kinetics of p53 binding to promoter sites in vivo.

Authors:  S T Szak; D Mays; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 6.  Posttranslational phosphorylation of mutant p53 protein in tumor development.

Authors:  Manabu Matsumoto; Mutsuo Furihata; Yuji Ohtsuki
Journal:  Med Mol Morphol       Date:  2006-06       Impact factor: 2.309

7.  Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53.

Authors:  A R Cuddihy; S Li; N W Tam; A H Wong; Y Taya; N Abraham; J C Bell; A E Koromilas
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  The expanding role of the Ehmt2/G9a complex in neurodevelopment.

Authors:  Steven J Deimling; Jonathan B Olsen; Vincent Tropepe
Journal:  Neurogenesis (Austin)       Date:  2017-05-02

9.  Phosphorylation of serine 18 regulates distinct p53 functions in mice.

Authors:  Hayla K Sluss; Heather Armata; Judy Gallant; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Phosphorylation at carboxyl-terminal S373 and S375 residues and 14-3-3 binding are not required for mouse p53 function.

Authors:  Ming Kei Lee; Kanaga Sabapathy
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.